Glucotrack, Inc. Files S-1/A Amendment
Ticker: GCTK · Form: S-1/A · Filed: Nov 4, 2024 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | S-1/A |
| Filed Date | Nov 4, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001, $1.68, $2,500,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, registration-statement, medical-devices
TL;DR
Glucotrack (GTRK) filed an S-1/A, looks like they're still prepping for something big.
AI Summary
Glucotrack, Inc. filed an S-1/A amendment on November 4, 2024, for its registration statement (No. 333-282158). The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus sector. Its principal executive offices are located at 301 Rte. 17 North, Suite 800, Rutherford, NJ 07070.
Why It Matters
This filing indicates Glucotrack, Inc. is actively pursuing a securities offering or other regulatory actions, which could impact its future financing and operational strategies.
Risk Assessment
Risk Level: medium — S-1/A filings often precede significant corporate events like IPOs or secondary offerings, which carry inherent market risks.
Key Numbers
- 3841 — SIC Code (Surgical & Medical Instruments & Apparatus industry)
- 98-0668934 — IRS Number (Employer Identification Number)
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- 333-282158 (dollar_amount) — Registration Statement Number
- November 4, 2024 (date) — Filing Date
- Integrity Applications, Inc. (company) — Former Company Name
- Paul Goode (person) — Chief Executive Officer
FAQ
What is the purpose of this S-1/A filing?
This is an amendment to a registration statement (No. 333-282158) filed by Glucotrack, Inc. under the Securities Act of 1933, indicating ongoing regulatory or offering activities.
When was this amendment filed?
The amendment was filed as of November 4, 2024.
What is Glucotrack, Inc.'s primary business sector?
Glucotrack, Inc. is classified under the SIC code 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Has the company's name changed previously?
Yes, Glucotrack, Inc. was formerly known as Integrity Applications, Inc. (name change on 20101203) and also previously as GlucoTrack, Inc. (name change on 20220328).
Where are Glucotrack, Inc.'s principal executive offices located?
The company's principal executive offices are located at 301 Rte. 17 North, Suite 800, Rutherford, NJ 07070.
Filing Stats: 4,541 words · 18 min read · ~15 pages · Grade level 16.1 · Accepted 2024-11-04 06:27:41
Key Financial Figures
- $0.001 — o shares of our common stock, par value $0.001 per share (the “Common Stock&rdqu
- $1.68 — Capital Market on October 31, 2024 was $1.68 per share. All share, Common Warrant an
- $2,500,000 — sted on Nasdaq to maintain a minimum of $2,500,000 in stockholders’ equity for conti
Filing Documents
- forms-1a.htm (S-1/A) — 617KB
- ex1-1.htm (EX-1.1) — 216KB
- ex4-25.htm (EX-4.25) — 132KB
- ex4-26.htm (EX-4.26) — 200KB
- ex4-27.htm (EX-4.27) — 164KB
- ex4-28.htm (EX-4.28) — 125KB
- ex10-24.htm (EX-10.24) — 276KB
- ex23-1.htm (EX-23.1) — 8KB
- ex23-1_001.jpg (GRAPHIC) — 6KB
- 0001493152-24-043401.txt ( ) — 1747KB
SELECTED FINANCIAL DATA
SELECTED FINANCIAL DATA 12
USE OF PROCEEDS
USE OF PROCEEDS 13 DIVIDEND POLICY 13 CAPITALIZATION 13
DESCRIPTION OF SECURITIES WE ARE OFFERING
DESCRIPTION OF SECURITIES WE ARE OFFERING 15 PLAN OF DISTRIBUTION 20 LEGAL MATTERS 22 EXPERTS 22 WHERE YOU CAN FIND MORE INFORMATION 22 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 22 i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we have filed with the SEC. You should rely only on the information contained in this prospectus or any related prospectus supplement. We have not authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. The information contained in this prospectus is accurate only on the date of this prospectus. Our business, financial condition, results of operations and prospects may have changed since such date. Other than as required under the federal securities laws, we undertake no obligation to publicly update or revise such information, whether as a result of new information, future events or any other reason. This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed, or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under “ Where You Can Find More Information .” This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any of our securities other than the securities covered hereby, nor does this prospectus constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. Persons who come into possession o